Catalysts for Cancer Institute and Hospital Chinese Academy of Medical Sciences
2 tracked
Apr 30, 2026
phase 2 completion
Cancer Institute and Hospital Chinese Academy of Medical Sciences โ capecitabine (Phase II Trial Completion)
capecitabine
โ
Apr 30, 2026
phase 2 completion
Cancer Institute and Hospital Chinese Academy of Medical Sciences โ lenvatinib (Phase II Trial Completion)
lenvatinib
โ